EURURO Vol. 72 No. 2

204 320

[3] Romanel A, Tandefelt DG, Conteduca V, et al. Plasma AR and
abiraterone-resistant prostate cancer. Sci Transl Med
2015;7:312re10 .
[4] Wyatt AW, Azad AA, Volik SV, et al. Genomic alterations in cell-free
DNA and enzalutamide resistance in castration-resistant prostate
cancer. JAMA Oncol 2016;2:1598–606
.
[5] Antonarakis ES, Lu C, Wang H, et al. AR-V7 and resistance to
enzalutamide and abiraterone in prostate cancer. N Engl J Med
2014;371:1028–38
[6] Scher HI, Lu D, Schreiber NA, et al. Association of AR-V7 on circu-
lating tumor cells as a treatment-specific biomarker with outcomes
and survival in castration-resistant prostate cancer. JAMA Oncol
2016;2:1441–9 .
[7] Scher HI, Graf RP, Schreiber NA, et al. Nuclear-specific AR-V7
protein localization is necessary to guide treatment selection in
metastatic castration-resistant prostate cancer. Eur Urol
2017;71:874–82 .
[8] Bernemann C, Schnoeller TJ, Luedeke M, et al. Expression of AR-V7
in circulating tumour cells does not preclude response to next
generation androgen deprivation therapy in patients with
castration resistant prostate cancer. Eur Urol 2017;71:1–3.
.
[9] Mu P, Zhang Z, Benelli M, et al. SOX2 promotes lineage plasticity and
antiandrogen resistance in TP53- and RB1-deficient prostate can-
cer. Science 2017;355:84–8
[10] Abeshouse A, Ahn J, Akbani R, et al. The molecular taxonomy of
primary prostate cancer. Cell 2015;163:1011–25
[11] Wu C, Wyatt AW, McPherson A, et al. Poly-gene fusion transcripts
and chromothripsis in prostate cancer. Genes Chromosomes Cancer
2012;51:1144–53 .
[12] Antonarakis ES, Lu C, Luber B, et al. Androgen Receptor splice
variant 7 and efficacy of taxane chemotherapy in patients with
metastatic castration-resistant prostate cancer. JAMA Oncol
2015;1:582–91
[13] Welti J, Rodrigues DN, Sharp A, et al. Analytical validation and
clinical qualification of a new immunohistochemical assay for
androgen receptor splice variant-7 protein expression in metastatic
castration-resistant prostate cancer. Eur Urol 2016;70:599–608.
.
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 2 0 1 – 2 0 4 204